Information About MRD
Leukemia is a deadly disease which if detected earlier can be treated in a cohesive manner.
There are countless individuals all over the world who are being effectively treated for this condition and they are able to continue with their normal lives later on.
However, just a few decades ago the results of these treatments was not very promising.
Despite intensive treatment plans the relapse rate in patients was very high.
The main cause of a relapse was the fact that a few cancerous cells sometimes were left behind in the body despite these treatments.
Since the technology was not very advanced it was impossible to detect these cells from the normal ones.
Later on, with the development of highly sensitive microbiological tests, this problem was resolved.
Now with the sophisticated tests available for MRD or minimal residual disease it is possible to detect and identify even a single cancer cell from a cluster of a million normal ones.
These tests are conducted by studying the DNA DeoxyriboNucleic Acid, RNA Ribonucleic acid or the protein in the patient's body.
Other than detecting the cancerous cells in the body, these tests can also identify tumors in their earliest stages.
With the use of minimal residual tests, the chances of survival for cancer patients and those suffering from leukemia in particular have increased considerably.
These tests are conducted by professionals under a controlled environment and are not offered at regular medical facilities, clinics, or even pathological laboratories.
Patients can get more information about the leukemia centers that offer these special tests from their clinics or doctors.
Patients are required to provide the centers with tissue samples to conduct these tests.
Minimal residual disease is mostly a post treatment condition, which can be treated effectively now with the help of these tests.
These tests can also indicate how the cells in the patient's body are recovering at different stages of the treatment.
The MRD tests allow the medical professionals to design alternative treatment plans for their patients who have a high risk of a relapse Minimal residual disease detection is now a mandatory process which, despite the complications, involves giving the patients and doctors a chance to detect this condition earlier ad treat it on atimely basis.
This is the key for winning against this disease.
There is still some confusion among healthcare professionals about MRD.
While some cancer cells inevitably grow back, there are considerable cases in which these cells remained dormant for years without causing any harm.
Thus, because of this reason, some of the medical professionals aim at only reducing the number of these cancerous cells to a safe level rather than eliminating them.
There are countless individuals all over the world who are being effectively treated for this condition and they are able to continue with their normal lives later on.
However, just a few decades ago the results of these treatments was not very promising.
Despite intensive treatment plans the relapse rate in patients was very high.
The main cause of a relapse was the fact that a few cancerous cells sometimes were left behind in the body despite these treatments.
Since the technology was not very advanced it was impossible to detect these cells from the normal ones.
Later on, with the development of highly sensitive microbiological tests, this problem was resolved.
Now with the sophisticated tests available for MRD or minimal residual disease it is possible to detect and identify even a single cancer cell from a cluster of a million normal ones.
These tests are conducted by studying the DNA DeoxyriboNucleic Acid, RNA Ribonucleic acid or the protein in the patient's body.
Other than detecting the cancerous cells in the body, these tests can also identify tumors in their earliest stages.
With the use of minimal residual tests, the chances of survival for cancer patients and those suffering from leukemia in particular have increased considerably.
These tests are conducted by professionals under a controlled environment and are not offered at regular medical facilities, clinics, or even pathological laboratories.
Patients can get more information about the leukemia centers that offer these special tests from their clinics or doctors.
Patients are required to provide the centers with tissue samples to conduct these tests.
Minimal residual disease is mostly a post treatment condition, which can be treated effectively now with the help of these tests.
These tests can also indicate how the cells in the patient's body are recovering at different stages of the treatment.
The MRD tests allow the medical professionals to design alternative treatment plans for their patients who have a high risk of a relapse Minimal residual disease detection is now a mandatory process which, despite the complications, involves giving the patients and doctors a chance to detect this condition earlier ad treat it on atimely basis.
This is the key for winning against this disease.
There is still some confusion among healthcare professionals about MRD.
While some cancer cells inevitably grow back, there are considerable cases in which these cells remained dormant for years without causing any harm.
Thus, because of this reason, some of the medical professionals aim at only reducing the number of these cancerous cells to a safe level rather than eliminating them.
Source...